| Literature DB >> 10753593 |
B Feldmann1, P M Jehle, S Mohan, G E Lang, G K Lang, J Brueckel, B O Boehm.
Abstract
In patients with diabetic retinopathy, elevated serum levels of total circulating insulin-like growth factor-I (IGF-I) have been implicated as an important mediator of the disease. There is no study, however, measuring free IGF-I levels in patients with diabetic retinopathy which mediate the biological effects of IGF-I and are modulated by a complex system of six specific IGF binding proteins (IGFBPs) and several IGFBP proteases. Copyright 2000 Harcourt Publishers Ltd.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10753593 DOI: 10.1054/ghir.2000.0140
Source DB: PubMed Journal: Growth Horm IGF Res ISSN: 1096-6374 Impact factor: 2.372